Iocarmic acid
Chemical compound
- V08AA08 (WHO)
- 3-(5-{[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]carbamoyl}pentanamido)-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid
- 10397-75-8
Y
- 25229
- DB13755 Y
- 23564
N
- 82PB24K6TZ
- D01099 Y
- DTXSID7023148
- Interactive image
- CNC(=O)c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(c(c(c(c2I)C(=O)O)I)C(=O)NC)I)I)C(=O)O)I
InChI
- InChI=1S/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42)N
- Key:SMQYOVYWPWASGU-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Iocarmic acid (trade name Dimer-X) is a pharmaceutical drug used as an iodinated contrast medium for X-ray imaging in the 1970s and 80s. Uses included imaging of the uterus and fallopian tubes. It was applied in form of its salt, meglumine iocarmate.[1][2]
It is not known to be marketed anywhere in the world in 2021.
References
- ^ Schütte HE (1982). "Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography". Diagnostic Imaging. 51 (6): 277–83. PMID 7173007.
- ^ Van Dellen JR, Lipschitz R (October 1973). "Meglumine iocarmate (Dimer-X) ventriculography". Clinical Radiology. 24 (4): 449–52. doi:10.1016/s0009-9260(73)80146-1. PMID 4621055.
- v
- t
- e
Contrast media (V08)
| Iodinated, Water soluble |
| ||||||
|---|---|---|---|---|---|---|---|
| Iodinated, Water insoluble |
| ||||||
| Non-iodinated |
| Paramagnetic | |
|---|---|
| Superparamagnetic |
|
| Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
